146923-55-9

Basic information

• Product Name: 3-(Thien-2-yl)-L-alanine, N-CBZ protected, (2S)-2-{[(Benzyloxy)carbonyl]amino}-3-(thien-2-yl)propanoic acid
• Synonyms: (2S)-2-Amino-3-(thien-2-yl)propanoic acid, N-CBZ protected;3-(Thien-2-yl)-L-alanine, N-CBZ protected, (2S)-2-{[(Benzyloxy)carbonyl]amino}-3-(thien-2-yl)propanoic acid
• CAS NO: 146923-55-9
• Molecular Weight: 305.354
• Mol File: 146923-55-9.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 3-(Thien-2-yl)-L-alanine, N-CBZ protected, (2S)-2-{[(Benzyloxy)carbonyl]amino}-3-(thien-2-yl)propanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(Thien-2-yl)-L-alanine, N-CBZ protected, (2S)-2-{[(Benzyloxy)carbonyl]amino}-3-(thien-2-yl)propanoic acid(146923-55-9)
• EPA Substance Registry System: 3-(Thien-2-yl)-L-alanine, N-CBZ protected, (2S)-2-{[(Benzyloxy)carbonyl]amino}-3-(thien-2-yl)propanoic acid(146923-55-9)

Safety Data

• Hazardous Substances Data: 146923-55-9(Hazardous Substances Data)

Upstream product

• 75-09-2 dichloromethane 
• 584-08-7 potassium carbonate 
• 501-53-1 benzyl chloroformate 
• 22951-96-8 L-3-(2-thienyl)alanine 
• 161282-35-5 tert-butyl (Z)-2-<(benzyloxy)carbonylamino>-3-(thiophen-2-yl)prop-2-enoate 
• 118553-53-0 rac-tert-butyl 2-<(benzyloxy)carbonylamino>-2-(dimethoxyphosphoryl)-acetate 
• 98-03-3 thiophene-2-carbaldehyde 
• 634920-02-8 4-thiophen-2-ylmethyl-oxazolidine-2,5-dione 
• 2021-58-1 rac-3-(2-thienyl)alanine 
• 394210-39-0 2,5-dioxo-4-thiophen-2-ylmethyl-oxazolidine-3-carboxylic acid benzyl ester 
• 161282-51-5 tert-butyl (S)-2-<(benzyloxy)carbonylamino>-3-(thiophen-2-yl)propanoate 
• 89525-07-5 (+/-)-2-<(benzyloxycarbonyl)amino>-2-(dimethoxyphosphinyl)acetic acid 
• 100945-15-1 N-(benzyloxycarbonyl)phosphonoglycine trimethyl ester 

Relevant articles and documents

PEPTIDOMIMETIC COMPOUNDS AND ANTIBODY-DRUG CONJUGATES THEREOF

This invention relates to peptidomimetic linkers and anti-body drug conjugates thereof, to pharmaceutical compositions containing them, and to their use in therapy for the prevention or treatment of cancer.

Asymmetric synthesis of α-amino acids via cinchona alkaloid-catalyzed kinetic resolution of urethane-protected α-amino acid N-carboxyanhydrides

-

HIV protease inhibitors

HIV protease inhibitors, obtainable by chemical synthesis, inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds, as well as pharmaceutical compositions that contain these compounds and optionally other anti-viral agents as active ingredients, are suitable for treating patients or hosts infected with the HIV virus, which is known to cause AIDS.